Chart-Typ:
Zeitraum:
| EQS-News: Immunic AG: Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology | Issuer: Immunic AG
/ Key word(s): Scientific publication
Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet... ► Artikel lesen |
| EQS-News: Immunic AG: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Issuer: Immunic AG
/ Key word(s): Quarter Results
Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
07.11.2024 / 12:30 CET/CEST
The... ► Artikel lesen |
| EQS-News: Immunic AG: Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update | Issuer: Immunic AG
/ Key word(s): Miscellaneous
Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
31.10.2024... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Provides Third Quarter 2024 Business Update | ENGLEWOOD, Colo., Nov. 14, 2024 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI Aerospace" or the "Company") today provided a business update and announced... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Provides Second Quarter 2024 Business Update | ENGLEWOOD, Colo., Aug. 14, 2024 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announces a business update and the filing of its quarterly report on... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Provides Update on Former Subsidiary Spin-Off Distribution and Proposed Business Combination with Damon Motors | ENGLEWOOD, Colo., May 28, 2024 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI" or the "Company") today provided an update on the previously announced spin-off (the "Spin-off") and proposed... ► Artikel lesen |
| Applied DNA Sciences: Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement | STONY BROOK, NY / ACCESSWIRE / October 30, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a... ► Artikel lesen |
| Applied DNA Sciences: Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 | STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president... ► Artikel lesen |
| Applied DNA Sciences: Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement | STONY BROOK, NY / ACCESSWIRE / September 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it received... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AGRIFY CORPORATION finden Sie auf Wallstreet Online.
